Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ferreira S. H. History of the development of inhibitors of angiotensin I conversion. Drugs. 1985;30 (Suppl 1):1–5. doi: 10.2165/00003495-198500301-00002. [DOI] [PubMed] [Google Scholar]
- Gomez H. J., Cirillo V. J., Irvin J. D. Enalapril: a review of human pharmacology. Drugs. 1985;30 (Suppl 1):13–24. doi: 10.2165/00003495-198500301-00004. [DOI] [PubMed] [Google Scholar]
- Johnston C. I., Arnolda L., Hiwatari M. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs. 1984 Mar;27(3):271–277. doi: 10.2165/00003495-198427030-00006. [DOI] [PubMed] [Google Scholar]
- Laragh J. H. Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone. Drugs. 1986;32 (Suppl 5):1–12. doi: 10.2165/00003495-198600325-00002. [DOI] [PubMed] [Google Scholar]
- Packer M., Lee W. H., Yushak M., Medina N. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med. 1986 Oct 2;315(14):847–853. doi: 10.1056/NEJM198610023151402. [DOI] [PubMed] [Google Scholar]
- Packer M. The role of vasodilator therapy in the treatment of severe chronic heart failure. Drugs. 1986;32 (Suppl 5):13–26. doi: 10.2165/00003495-198600325-00003. [DOI] [PubMed] [Google Scholar]
- Todd P. A., Heel R. C. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs. 1986 Mar;31(3):198–248. doi: 10.2165/00003495-198631030-00002. [DOI] [PubMed] [Google Scholar]